Kita, Japan

Kikuo Ohtomo

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Hodogaya Chemical Co., Ltd., Mochida Pharmaceutical Co., Ltd.. Active years: 1992.


% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kikuo Ohtomo: Innovator in Pharmaceutical Chemistry

Introduction

Kikuo Ohtomo is a notable inventor based in Kita, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patent related to novel compounds with therapeutic applications. His work has implications for the treatment of various diseases and disorders.

Latest Patents

Ohtomo holds a patent for 4,5-dihydro-6H-imidazo[4,5,1-ij]quinolin-6-one-6-oxime-O-sulfonic acid. This invention relates to novel compounds that exhibit potent hypotensive, anti-oedematous, and diuretic effects. The patent also details processes for producing these compounds and their intermediate forms, which are crucial for synthesizing the final products. The compounds are particularly useful in pharmaceutical and veterinary compositions aimed at treating specific health conditions.

Career Highlights

Throughout his career, Kikuo Ohtomo has worked with prominent companies in the pharmaceutical industry, including Mochida Pharmaceutical Co., Ltd. and Hodogaya Chemical Co., Ltd. His expertise in the synthesis of complex chemical compounds has positioned him as a valuable asset in the field.

Collaborations

Ohtomo has collaborated with notable colleagues such as Hitoshi Inaba and Kazumi Nishijima. These partnerships have likely contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Kikuo Ohtomo's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a significant inventor in the industry. His work continues to impact the development of effective treatments for various medical conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…